Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-098531
Filing Date
2024-08-19
Accepted
2024-08-19 16:15:03
Documents
2
Period of Report
2024-08-09

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 9666
2 EX-24 beam-ex24.htm EX-24 13740
  Complete submission text file 0000950170-24-098531.txt   24846
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Issuer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BEAM THERAPEUTICS, 238 MAIN STREET 9TH FLOOR CAMBRIDGE MA 02142
Business Address
Cavanagh Bethany J (Reporting) CIK: 0002033155 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39208 | Film No.: 241220709